{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:59:37Z","timestamp":1790276377638,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117446","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:30:51Z","timestamp":1790069451000},"page":"117446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["S-propargyl-L-cysteine attenuates ketamine induced schizophrenia-like behaviors and neuroinflammation in mice via inhibition of NF-\u03baB\/NLRP3 inflammasome-mediated pyroptosis"],"prefix":"10.1016","volume":"189","author":[{"given":"Hanxuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjia","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kuan","family":"Lio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Ieng","family":"Vong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoran","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iok Ian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Zhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2026.117446_bb0005","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/med.22042","article-title":"Beyond dopamine: novel strategies for schizophrenia treatment","volume":"44","author":"Dudzik","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"10323","key":"10.1016\/j.intimp.2026.117446_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.intimp.2026.117446_bb0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S1092852918001050","article-title":"Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder","volume":"24","author":"Solmi","year":"2019","journal-title":"CNS Spectr."},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0020","article-title":"Second-generation antipsychotics and extrapyramidal adverse effects","volume":"2014","author":"Divac","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2026.117446_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2017.07.037","article-title":"Hyperprolactinaemia in first episode psychosis - A longitudinal assessment","volume":"189","author":"Lally","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.intimp.2026.117446_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neubiorev.2017.01.029","article-title":"Altered reward anticipation: potential explanation for weight gain in schizophrenia?","volume":"75","author":"Grimm","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2026.117446_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2016.05.003","article-title":"Secondary negative symptoms \u2014 A review of mechanisms, assessment and treatment","volume":"186","author":"Kirschner","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.intimp.2026.117446_bb0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fpsyt.2018.00501","article-title":"Hydrogen sulfide affects radical formation in the hippocampus of LPS treated rats and the effect of antipsychotics on hydrogen sulfide forming enzymes in human cell lines","volume":"9","author":"Sommer","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"24","key":"10.1016\/j.intimp.2026.117446_bb0045","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1111\/febs.16944","article-title":"Treatment with aripiprazole and N-acetylcysteine affects anaerobic cysteine metabolism in the hippocampus and reverses schizophrenia-like behavior in the neurodevelopmental rat model of schizophrenia","volume":"290","author":"G\u00f3rny","year":"2023","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.intimp.2026.117446_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70278","article-title":"Hydrogen sulfide alleviates schizophrenia-like behavior through regulating apoptosis by S-sulfhydrylation modification","volume":"31","author":"Du","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2026.117446_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.niox.2014.11.010","article-title":"H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential","volume":"46","author":"Gemici","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.intimp.2026.117446_bb0060","article-title":"Hydrogen sulfide: a multitarget therapeutic for neuroinflammation in neurodegenerative diseases","volume":"9","author":"Zhang","year":"2026","journal-title":"Research"},{"issue":"8","key":"10.1016\/j.intimp.2026.117446_bb0065","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/antiox12081570","article-title":"Role of hydrogen Sulfide in inflammatory bowel disease","volume":"12","author":"Stummer","year":"2023","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.intimp.2026.117446_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11040732","article-title":"Sp1 S-sulfhydration induced by hydrogen sulfide inhibits inflammation via HDAC6\/MyD88\/NF-\u03baB signaling pathway in adjuvant-induced arthritis","volume":"11","author":"Li","year":"2022","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.intimp.2026.117446_bb0075","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1007\/s11010-025-05220-3","article-title":"Exogenous hydrogen sulfide improves non-alcoholic fatty liver disease by inhibiting endoplasmic reticulum stress\/NLRP3 inflammasome pathway","volume":"480","author":"Fu","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2026.117446_bb0080","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/antiox13040406","article-title":"Sulforaphane inhibits IL-1\u03b2-induced IL-6 by suppressing ROS production, AP-1, and STAT3 in colorectal Cancer HT-29 cells","volume":"13","author":"Sah","year":"2024","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.intimp.2026.117446_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jphs.2024.05.001","article-title":"H2S prevents the disruption of the blood-brain barrier in rats with prenatal hyperhomocysteinemia","volume":"155","author":"Yakovlev","year":"2024","journal-title":"J. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117446_bb0090","first-page":"845","article-title":"Hydrogen sulfide improves vascular endothelial function in hypertensive states through SIRT6 anti-inflammatory signaling","volume":"58","author":"Lu","year":"2025","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"4","key":"10.1016\/j.intimp.2026.117446_bb0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","author":"Halstead","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.intimp.2026.117446_bb0100","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41380-024-02529-1","article-title":"Genetic contribution to microglial activation in schizophrenia","volume":"29","author":"Koskuvi","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.intimp.2026.117446_bb0105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/antiox13060709","article-title":"The underlying neurobiological mechanisms of psychosis: focus on neurotransmission dysregulation, neuroinflammation, oxidative stress, and mitochondrial dysfunction","volume":"13","author":"Rawani","year":"2024","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.intimp.2026.117446_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00702-022-02567-5","article-title":"Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors","volume":"130","author":"Schmitt","year":"2023","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.intimp.2026.117446_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5498\/wjp.v12.i4.541","article-title":"Abnormal synaptic plasticity and impaired cognition in schizophrenia","volume":"12","author":"Wu","year":"2022","journal-title":"World J Psychiatry."},{"issue":"3","key":"10.1016\/j.intimp.2026.117446_bb0120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.mehy.2009.03.030","article-title":"Calcium sulfide (CaS), a donor of hydrogen sulfide (H2S): A new antihypertensive drug?","volume":"73","author":"Li","year":"2009","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.intimp.2026.117446_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2131\/jts.44.107","article-title":"Hydrogen sulfide donor NaHS causes bronchitis with enhanced respiratory secretion in rats","volume":"44","author":"Unuma","year":"2019","journal-title":"J. Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2026.117446_bb0130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/ars.2009.2947","article-title":"Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H2S production","volume":"12","author":"Wang","year":"2010","journal-title":"Antioxid. Redox Signal."},{"issue":"15","key":"10.1016\/j.intimp.2026.117446_bb0135","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1089\/ars.2013.5449","article-title":"S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen Sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3","volume":"20","author":"Kan","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.intimp.2026.117446_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70243","article-title":"H2S donor SPRC ameliorates ischemic stroke by upregulating CD24","volume":"31","author":"Wang","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2026.117446_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.redox.2016.08.011","article-title":"S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway","volume":"10","author":"Wu","year":"2016","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2010.09.001","article-title":"S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-\u03baB pathway in rats","volume":"25","author":"Gong","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.intimp.2026.117446_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/biology15030222","article-title":"Psychosis: the utility of ketamine as a pharmacological model of psychotic-like symptoms in rodents: a review of dosage regimens","volume":"15","author":"Rice","year":"2026","journal-title":"Biology"},{"issue":"11","key":"10.1016\/j.intimp.2026.117446_bb0160","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/mp.2017.4","article-title":"Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice","volume":"22","author":"Busquets-Garcia","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0165","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12035-025-05482-4","article-title":"Pachymic acid promotes ILC2 migration to the brain via dynein axonemal heavy chain 9 upregulation","volume":"63","author":"Shen","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12974-021-02295-9","article-title":"Blockade of the NLRP3\/caspase-1 axis attenuates ketamine-induced hippocampus pyroptosis and cognitive impairment in neonatal rats","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117446_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2026.121235","article-title":"Fujian tablets promote corticospinal tract remodeling and improve motor function in MCAO rats by regulating BDNF shearing enzyme-mediated proBDNF\/mBDNF balance","volume":"361","author":"Gao","year":"2026","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-023-05182-0","article-title":"Abnormal expression of miR-3653-3p, caspase 1, IL-1\u03b2 in peripheral blood of schizophrenia","volume":"23","author":"Zhao","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.intimp.2026.117446_bb0185","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.niox.2013.06.081","article-title":"P19 S-propargyl-cysteine (SPRC) attenuates cognitive impairment in APP\/PS1 mice and protects neurons against glial overactivation induced by A\u03b21\u221240 via modulation of cystathionine-\u03b2-synthase","volume":"31","author":"Hong","year":"2013","journal-title":"Nitric Oxide."},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0190","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/10717544.2021.1921075","article-title":"A novel dendritic mesoporous silica based sustained hydrogen sulfide donor for the alleviation of adjuvant-induced inflammation in rats","volume":"28","author":"Yu","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2026.117446_bb0195","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuro.2014.06.002","article-title":"Existence of glia mitigated ketamine-induced neurotoxicity in neuron\u2013glia mixed cultures of neonatal rat cortex and the glia-mediated protective effect of 2-PMPA","volume":"44","author":"Zuo","year":"2014","journal-title":"NeuroToxicology"},{"issue":"9","key":"10.1016\/j.intimp.2026.117446_bb0200","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1017\/S003329172400014X","article-title":"Temporal changes in brain morphology related to inflammation and schizophrenia: an omnigenic mendelian randomization study","volume":"54","author":"Liu","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.intimp.2026.117446_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177469","article-title":"Unraveling the potential of neuroinflammation and autophagy in schizophrenia","volume":"997","author":"Tao","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117446_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.9758\/cpn.2013.11.3.107","article-title":"The neuroimmunology of schizophrenia","volume":"11","author":"M A","year":"2013","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"10","key":"10.1016\/j.intimp.2026.117446_bb0215","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1176\/appi.ajp.2019.19080865","article-title":"Early detection and preventive intervention in schizophrenia: from fantasy to reality","volume":"176","author":"Lieberman","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2011.09.022","article-title":"The role of BDNF in the pathophysiology and treatment of schizophrenia","volume":"46","author":"Favalli","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.intimp.2026.117446_bb0225","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jpsychires.2022.10.022","article-title":"Effects of brain-derived neurotrophic factor (BDNF) on the schizophrenia model of animals","volume":"156","author":"Shi","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.117446_bb0230","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/schbul\/sbaa062","article-title":"Interrelationships between BDNF, superoxide dismutase, and cognitive impairment in drug-naive first-episode patients with schizophrenia","volume":"46","author":"Xiu","year":"2020","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","article-title":"Reduced serum BDNF levels in schizophrenic patients on Clozaril or typical antipsychotics","volume":"41","author":"Grillo","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"46","key":"10.1016\/j.intimp.2026.117446_bb0240","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036156","article-title":"Gas therapy strategies for depression and schizophrenia: A review","volume":"102","author":"Tao","year":"2023","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.intimp.2026.117446_bb0245","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s00213-018-4923-7","article-title":"Decreased plasma levels of gasotransmitter hydrogen sulfide in patients with schizophrenia: correlation with psychopathology and cognition","volume":"235","author":"Xiong","year":"2018","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.intimp.2026.117446_bb0250","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910695","article-title":"Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology","volume":"11","author":"Ide","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2026.117446_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116254","article-title":"The role of hydrogen sulfide regulation of pyroptosis in different pathological processes","volume":"268","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2026.117446_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26020520","article-title":"HERV-W env induces neuron pyroptosis via the NLRP3\u2013CASP1\u2013GSDMD pathway in recent-onset schizophrenia","volume":"26","author":"Jia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2026.117446_bb0265","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1007\/s12033-024-01252-0","article-title":"Identification of Pyroptosis-related molecular subtypes and diagnostic model development in major depressive disorder","volume":"67","author":"Feng","year":"2025","journal-title":"Mol. Biotechnol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117446_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12091245","article-title":"Hydrogen sulfide attenuates neuroinflammation by inhibiting the NLRP3\/Caspase-1\/GSDMD pathway in retina or brain neuron following rat ischemia\/reperfusion","volume":"12","author":"Yang","year":"2022","journal-title":"Brain Sci."},{"issue":"11","key":"10.1016\/j.intimp.2026.117446_bb0275","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/bbb\/zbac149","article-title":"Diallyl trisulfide attenuates alcohol-induced hepatocyte pyroptosis via elevation of hydrogen sulfide","volume":"86","author":"Zhu","year":"2022","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.intimp.2026.117446_bb0280","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jad.2023.10.040","article-title":"GDF11 mediates H2S to prevent chronic stress-induced cognitive impairment by reducing hippocampal NLRP3\/caspase-1-dependent pyroptosis","volume":"344","author":"Wang","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.intimp.2026.117446_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fceld.2024.1503799","article-title":"Regulation of pyroptosis by NF-\u03baB signaling","volume":"3","author":"Yang","year":"2025","journal-title":"Front. Cell Death"},{"issue":"4","key":"10.1016\/j.intimp.2026.117446_bb0290","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00592-022-02021-8","article-title":"LncRNA SNHG16 regulates RAS and NF-\u03baB pathway-mediated NLRP3 inflammasome activation to aggravate diabetes nephropathy through stabilizing TLR4","volume":"60","author":"Liu","year":"2023","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117446_bb0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tins.2019.11.005","article-title":"Fiery cell death: Pyroptosis in the central nervous system","volume":"43","author":"McKenzie","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2026.117446_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116575","article-title":"Targeting of inflammation and prostaglandins by nonsteroidal anti-inflammatory drugs in schizophrenia: A narrative review","volume":"351","author":"Al-kuraishy","year":"2025","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.117446_bb0305","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40263-024-01151-7","article-title":"Negative symptoms in schizophrenia: an update on research assessment and the current and upcoming treatment landscape","volume":"39","author":"Govil","year":"2025","journal-title":"CNS Drugs"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926012932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:06:05Z","timestamp":1790273165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926012932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":61,"alternative-id":["S1567576926012932"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117446","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-propargyl-L-cysteine attenuates ketamine induced schizophrenia-like behaviors and neuroinflammation in mice via inhibition of NF-\u03baB\/NLRP3 inflammasome-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117446"}}